ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 250 filers reported holding ACADIA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $268 | -63.6% | 12,873 | -67.1% | 0.03% | -60.3% |
Q1 2023 | $736 | -99.8% | 39,075 | +80.8% | 0.07% | +94.3% |
Q3 2022 | $354,000 | -63.9% | 21,618 | -46.6% | 0.04% | -69.8% |
Q1 2022 | $981,000 | +371.6% | 40,490 | +374.1% | 0.12% | +452.4% |
Q2 2021 | $208,000 | -39.9% | 8,540 | +19.7% | 0.02% | -59.6% |
Q2 2020 | $346,000 | +8.5% | 7,137 | -4.4% | 0.05% | +2.0% |
Q4 2019 | $319,000 | -20.1% | 7,465 | -32.7% | 0.05% | -27.1% |
Q3 2019 | $399,000 | +94.6% | 11,087 | +44.6% | 0.07% | +100.0% |
Q2 2019 | $205,000 | -28.8% | 7,667 | -57.0% | 0.04% | -30.0% |
Q4 2018 | $288,000 | – | 17,815 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 563,200 | $16,243,000 | 9.48% |
Avoro Capital Advisors LLC | 1,486,460 | $42,870,000 | 8.66% |
Baker Brothers Advisors | 25,819,768 | $744,642,000 | 7.30% |
SECTORAL ASSET MANAGEMENT INC | 1,176,543 | $33,932,000 | 3.76% |
HARVEY CAPITAL MANAGEMENT INC | 251,825 | $7,262,000 | 3.38% |
ACUTA CAPITAL PARTNERS, LLC | 300,000 | $8,652,000 | 3.22% |
Palo Alto Investors LP | 1,532,030 | $44,184,000 | 2.52% |
Ghost Tree Capital, LLC | 350,000 | $10,094,000 | 2.43% |
EMORY UNIVERSITY | 76,121 | $2,195,000 | 2.16% |
WEATHERBIE CAPITAL, LLC | 576,784 | $16,634,000 | 2.09% |